Consolidated Planning Corp Buys 130 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Consolidated Planning Corp increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,229 shares of the medical equipment provider’s stock after buying an additional 130 shares during the period. Consolidated Planning Corp’s holdings in Intuitive Surgical were worth $4,295,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $60,260,000. Avion Wealth lifted its position in Intuitive Surgical by 2.9% during the fourth quarter. Avion Wealth now owns 962 shares of the medical equipment provider’s stock valued at $502,000 after purchasing an additional 27 shares during the last quarter. Avidian Wealth Enterprises LLC lifted its position in Intuitive Surgical by 37.3% during the fourth quarter. Avidian Wealth Enterprises LLC now owns 901 shares of the medical equipment provider’s stock valued at $470,000 after purchasing an additional 245 shares during the last quarter. Great Lakes Retirement Inc. grew its stake in shares of Intuitive Surgical by 1.6% in the 4th quarter. Great Lakes Retirement Inc. now owns 3,215 shares of the medical equipment provider’s stock worth $1,678,000 after buying an additional 50 shares in the last quarter. Finally, Capital Advisors Inc. OK raised its position in shares of Intuitive Surgical by 1.5% during the 4th quarter. Capital Advisors Inc. OK now owns 129,751 shares of the medical equipment provider’s stock valued at $67,725,000 after buying an additional 1,858 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $589.61 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $210.01 billion, a price-to-earnings ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. The stock’s 50-day simple moving average is $556.91 and its 200-day simple moving average is $516.98.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on ISRG shares. Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays boosted their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.